Kenneth Moch

BIO Board of Directors (Health Section Governing Board and Emerging Companies Section Governing Board.) Chair, BIO Bioethics Committee. Co-Chair, ECS Strategy and Policy Committee. ECS Secretary, 2011 - 2014, 2016- 2020. Co-Chair, Executive Committee, BIO 2005 Philadelphia (Annual International Convention).

The mission of the Working Group on Compassionate Use and Preapproval Access (CUPA) is to advance research, policy, and education regarding the ethical issues surrounding access to investigational medical products. CUPA strives to ensure the fair and transparent treatment of all patients.

Founded in 2014, CUPA is part of NYU Langone’s Division of Medical Ethics. CUPA studies the many ethical issues surrounding patient access to investigational medical products, through both clinical… Show more

The mission of the Working Group on Compassionate Use and Preapproval Access (CUPA) is to advance research, policy, and education regarding the ethical issues surrounding access to investigational medical products. CUPA strives to ensure the fair and transparent treatment of all patients.

Founded in 2014, CUPA is part of NYU Langone’s Division of Medical Ethics. CUPA studies the many ethical issues surrounding patient access to investigational medical products, through both clinical trials and nontrial pathways. Show less

The Endless Frontier Labs is dedicated to advancing human welfare through science and technology based entrepreneurship.

Founded at New York University’s Stern School of Business, Endless Frontier Labs guides founders through a performance-based mentoring process. Endless Frontier Labs is open to early-stage science and technology startups. The program is suitable for founders from around the world seeking connections to the thriving New York startup ecosystem or U.S. markets.

The mission of the Alzheimer's Drug Discovery Foundation is to rapidly accelerate the discovery of drugs to prevent, treat and cure Alzheimer's disease.

The Business Review Board reviews grants applications by biotechnology companies. It comprises members from various backgrounds, including venture capital and the biotechnology and pharmaceutical industries.

M2Gen® is an informatics solution company dedicated to advancing personalized medicine by using high quality tissue, clinical data and molecular technology to accelerate the discovery and delivery of personalized medicine. Using a rapid learning approach based on Moffitt's Total Cancer Care protocol, the goal of M2Gen is to accelerate the science of precision medicine by creating evidence and knowledge-based solutions that identify a patient's susceptibility to disease, predict how the patient… Show more

M2Gen® is an informatics solution company dedicated to advancing personalized medicine by using high quality tissue, clinical data and molecular technology to accelerate the discovery and delivery of personalized medicine. Using a rapid learning approach based on Moffitt's Total Cancer Care protocol, the goal of M2Gen is to accelerate the science of precision medicine by creating evidence and knowledge-based solutions that identify a patient's susceptibility to disease, predict how the patient will respond to a particular drug, and match patients to the best therapies for an optimal treatment outcome. Show less

Project Redwood Is a nonprofit partnership of Stanford GSB alumni that provides funding, expertise and connections to social entrepreneurs who address the challenge of global poverty.

BioNJ is the life sciences trade association for New Jersey, representing close to 400 research-based life sciences organizations across the healthcare ecosystem from the largest biopharmaceutical companies to early stage start-ups for nearly 30 years. Because Patients Can’t Wait®, BioNJ is dedicated to ensuring a vibrant ecosystem where Science is Supported, Companies are Created, Drugs are Developed and Patients Have Access to Lifesaving Medicines.